
Agenus AGEN
$ 4.64
-4.04%
Annual report 2025
added 03-16-2026
Agenus DIO Ratio 2011-2026 | AGEN
Annual DIO Ratio Agenus
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 0.163 | 0.25 | 0.339 | 0.457 | 1.56 | - | 0.52 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.56 | 0.163 | 0.549 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 327.0 | -1.92 % | $ 42.8 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 21.94 | 1.2 % | $ 1.03 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Akebia Therapeutics
AKBA
|
147 | $ 1.4 | -10.0 % | $ 360 M | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.22 | -0.59 % | $ 451 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 24.2 | -1.55 % | $ 3.08 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.59 | -1.1 % | $ 6.83 B | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.53 | 2.68 % | $ 407 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M |